The antidepressant that doesn't wreck
your sex life or your waistline

You've heard that antidepressants can cause weight gain and kill your sex drive. Maybe you've experienced it yourself. Maybe it's the reason you stopped taking your medication, or the reason you've been avoiding the conversation with your doctor entirely.

You're not wrong to be concerned. But here's what most people don't realize: not all antidepressants work the same way, and one of the most commonly prescribed options doesn't carry those particular side effects at all.

Let's talk about Wellbutrin (bupropion) and how it compares to the SSRIs.

First, What Are SSRIs and Why Are They So Popular?

SSRIs, or selective serotonin reuptake inhibitors, include medications like Lexapro (escitalopram), Zoloft (sertraline), Prozac (fluoxetine), Paxil (paroxetine), and Celexa (citalopram). They work by increasing serotonin levels in the brain and are the most widely prescribed class of antidepressants in the world.

They're popular for good reason. In the largest network meta-analysis of antidepressants ever conducted, covering over 116,000 patients across 522 trials, all 21 antidepressants studied were more effective than placebo. Among them, escitalopram and sertraline stood out for having the best balance of efficacy and tolerability.

But "well tolerated" doesn't mean "no side effects." And two side effects in particular drive a huge number of people to stop their medication.

The Sexual Side Effect Problem

Sexual dysfunction is the most problematic adverse effect of SSRIs. It can include decreased libido, difficulty with arousal, and delayed or absent orgasm. Studies estimate this affects up to 40% of patients taking SSRIs.

This isn't a minor inconvenience. It affects relationships, self-esteem, and quality of life. And because many people feel uncomfortable bringing it up with their doctor, they simply stop taking the medication instead.

Bupropion is fundamentally different here. In a meta-analysis of seven randomized controlled trials directly comparing bupropion to SSRIs (sertraline, fluoxetine, paroxetine, and escitalopram), SSRI therapy resulted in significantly higher rates of sexual side effects compared to both bupropion and placebo. Bupropion caused no more sexual dysfunction than placebo.

A placebo-controlled neuroimaging study confirmed this at the brain level: paroxetine (an SSRI) reduced neural activation in brain regions involved in sexual arousal and motivation, while bupropion left those responses unchanged and even enhanced activity in some areas.

The Weight Question

Weight gain is the other major concern. And the data here is nuanced.

A large observational study of over 183,000 patients across eight U.S. health systems compared weight changes among eight first-line antidepressants over six months. Bupropion consistently showed the least weight gain. Compared to sertraline (the reference), bupropion users actually lost a small amount of weight (difference of negative 0.22 kg), while escitalopram (positive 0.41 kg), paroxetine (positive 0.37 kg), and duloxetine (positive 0.34 kg) were associated with more weight gain. Bupropion was also associated with a 15% reduced risk of gaining 5% or more of baseline body weight.

An Endocrine Society guideline on pharmacological management of obesity states that bupropion is the only antidepressant that consistently causes weight loss. During clinical trials, it suppressed appetite and food cravings and significantly decreased body weight.

To be clear: the weight differences between most antidepressants are small in absolute terms. But for patients who are already struggling with weight, or for whom weight gain would be a reason to stop treatment, these differences matter.

So Is Bupropion Just as Effective for Depression?

Yes. Multiple head-to-head trials and meta-analyses have confirmed that bupropion has comparable efficacy to SSRIs for major depressive disorder. A pooled analysis of seven randomized controlled trials found identical response rates (62% vs. 63%) and remission rates (47% vs. 47%) between bupropion and SSRIs. A survival analysis of those same trials found no difference in time to first response or first remission.

A separate non-inferiority trial of 534 patients confirmed that bupropion XL was non-inferior to escitalopram for depression, with similar response and remission rates.

Where Bupropion Falls Short

This is the part that matters just as much as the advantages.

Bupropion is not FDA approved for any anxiety disorder. SSRIs like escitalopram and sertraline are first-line treatments for generalized anxiety disorder, social anxiety disorder, panic disorder, PTSD, and OCD. An NEJM review on generalized anxiety disorder specifically noted that trials have not consistently shown efficacy of bupropion for anxiety, and it is not recommended for that indication.

Some clinical data suggest bupropion may reduce anxiety symptoms in patients with comorbid depression and anxiety, performing comparably to SSRIs in that specific context. But its stimulating properties (it acts on dopamine and norepinephrine, not serotonin) can also provoke anxiety, particularly at higher doses. For patients whose primary problem is anxiety, an SSRI or SNRI remains the better choice.

Bupropion also carries a dose-related seizure risk. The risk is small (less than 1%), but it means bupropion is contraindicated in patients with a seizure disorder, a current or prior diagnosis of anorexia nervosa or bulimia, or those undergoing abrupt discontinuation of alcohol, benzodiazepines, or barbiturates.

Unlike SSRIs, which can often be started at their usual effective dose, bupropion should be started at a lower dose and increased after one week.

Bupropion should also be avoided in pregnancy, where SSRIs like sertraline have a more established safety profile.

The Emotional Blunting Question

Some patients on SSRIs describe a feeling of emotional flatness, sometimes called "emotional blunting." They can function, but they feel less joy, less sadness, less of everything. This is a real phenomenon, though it remains somewhat controversial in the literature and is difficult to measure objectively.

Bupropion, because it works on dopamine rather than serotonin, is often perceived as more "activating." Patients frequently describe feeling more energized and motivated on bupropion compared to SSRIs. Some providers specifically choose bupropion for patients whose depression is characterized by fatigue, low motivation, and anhedonia (the inability to feel pleasure), as it may provide greater relief for these symptoms.

Can You Take Both?

Yes. Bupropion is commonly used in combination with SSRIs. This strategy can augment the antidepressant effect for patients who haven't fully responded to an SSRI alone, and it may help counteract SSRI-induced sexual side effects and weight gain. The combination is generally well tolerated, though providers should monitor for potential drug interactions and the additive seizure risk.

The Bottom Line

Bupropion and SSRIs are equally effective for depression. The choice between them comes down to side effect priorities and what else is being treated.

If your primary concern is depression and you want to minimize sexual side effects and weight gain, bupropion is a strong first choice. If anxiety is a major part of the picture, an SSRI is likely the better starting point.

And if you've been avoiding treatment because you're afraid of side effects, know this: there are options. The goal isn't to find a perfect medication. It's to find one that treats your symptoms without creating new problems that make you want to stop. That conversation with your provider is worth having.